Metabolic syndrome and cancer.


Since its first description by Reavan in 1988, accepted criteria for clinical identification of the components of metabolic syndrome have been promulgated by the National Cholesterol Education Program/Adult Treatment Panel III (NCEP/ATP III) and the World Health Organization (WHO) as well as the International Diabetes Federation (IDF), and the American… (More)
DOI: 10.1089/met.2008.0065

3 Figures and Tables


  • Presentations referencing similar topics